Copper complexes and experimental-induced inflammation and arthritis.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001168:Arthritis / Q000188:drug therapy*; D001169:Arthritis, Experimental / Q000188:drug therapy*; D002351:Carrageenan; D003300:Copper / Q000627:therapeutic use*; D004487:Edema / Q000139:chemically induced; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D009169:Mycobacterium tuberculosis; D009761:Nystatin; D051381:Rats
D000893:Anti-Inflammatory Agents; D009761:Nystatin; D003300:Copper; D002351:Carrageenan